Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations of pre‐mRNA splicing in cancer
Zane Kalniņa, Pawel Zayakin, Kariīna Silin̨a, et al.
Genes Chromosomes and Cancer (2005) Vol. 42, Iss. 4, pp. 342-357
Closed Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zöller
Nature reviews. Cancer (2011) Vol. 11, Iss. 4, pp. 254-267
Closed Access | Times Cited: 1056
Mechanism of alternative splicing and its regulation
Yan Wang, Jing Liu, Bo Huang, et al.
Biomedical Reports (2014) Vol. 3, Iss. 2, pp. 152-158
Open Access | Times Cited: 374
Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing
Michael Krawczak, Nick Thomas, Bernd Hundrieser, et al.
Human Mutation (2006) Vol. 28, Iss. 2, pp. 150-158
Open Access | Times Cited: 350
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Hyunchul Jung, Donghoon Lee, Jongkeun Lee, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1242-1248
Closed Access | Times Cited: 338
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Dawid G. Nowak, Jeanette Woolard, Elianna Amin, et al.
Journal of Cell Science (2008) Vol. 121, Iss. 20, pp. 3487-3495
Open Access | Times Cited: 331
CD44-Targeted Nanocarrier for Cancer Therapy
Prashant Kesharwani, Rahul Chadar, Afsana Sheikh, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 115
Unbalanced alternative splicing and its significance in cancer
Julian P. Venables
BioEssays (2006) Vol. 28, Iss. 4, pp. 378-386
Closed Access | Times Cited: 297
Alternative splicing: an emerging topic in molecular and clinical oncology
María J. Pajares, Teresa Ezponda, Raúl Catena, et al.
The Lancet Oncology (2007) Vol. 8, Iss. 4, pp. 349-357
Closed Access | Times Cited: 267
Pathophysiological Roles of ASK1-MAP Kinase Signaling Pathways
Hiroaki Nagai, Takuya Noguchi, Kohsuke Takeda, et al.
BMB Reports (2007) Vol. 40, Iss. 1, pp. 1-6
Open Access | Times Cited: 240
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression
Brian Carpenter, Catriona MacKay, Ayham Alnabulsi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2005) Vol. 1765, Iss. 2, pp. 85-100
Closed Access | Times Cited: 222
Defective splicing, disease and therapy: searching for master checkpoints in exon definition
Emanuele Buratti
Nucleic Acids Research (2006) Vol. 34, Iss. 12, pp. 3494-3510
Open Access | Times Cited: 212
Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies
Peter Ebbesen, Erik O. Pettersen, Thomas A. Gorr, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2009) Vol. 24, Iss. sup1, pp. 1-39
Open Access | Times Cited: 209
Alternative splicing in cancer: Noise, functional, or systematic?
Rolf I. Skotheim, Matthias Nees
The International Journal of Biochemistry & Cell Biology (2007) Vol. 39, Iss. 7-8, pp. 1432-1449
Closed Access | Times Cited: 205
Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers
Maria Capra, Paolo Nucíforo, Stefano Confalonieri, et al.
Cancer Research (2006) Vol. 66, Iss. 16, pp. 8147-8154
Open Access | Times Cited: 192
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Blood (2007) Vol. 110, Iss. 3, pp. 1022-1024
Open Access | Times Cited: 158
Multiple Alternative Splicing Markers for Ovarian Cancer
Roscoe Klinck, Anne Bramard, Lyna Inkel, et al.
Cancer Research (2008) Vol. 68, Iss. 3, pp. 657-663
Open Access | Times Cited: 157
CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells
Margot Zöller
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 141
Design of a Bioactive Small Molecule That Targets the Myotonic Dystrophy Type 1 RNA via an RNA Motif–Ligand Database and Chemical Similarity Searching
Raman Parkesh, Jessica L. Childs‐Disney, Masayuki Nakamori, et al.
Journal of the American Chemical Society (2012) Vol. 134, Iss. 10, pp. 4731-4742
Open Access | Times Cited: 130
Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing
Wei Jiang, Liang Chen
Computational and Structural Biotechnology Journal (2020) Vol. 19, pp. 183-195
Open Access | Times Cited: 91
Comparative analysis of cancer genes in the human and chimpanzee genomes
Xosé S. Puente, Gloria Velasco, Ana Gutiérrez‐Fernández, et al.
BMC Genomics (2006) Vol. 7, Iss. 1
Open Access | Times Cited: 115
Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts
Luke F. Peterson, Anita Boyapati, E. Ahn, et al.
Blood (2007) Vol. 110, Iss. 3, pp. 799-805
Open Access | Times Cited: 114
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity
Sebastian Oltean, Brian S. Sorg, Todd R. Albrecht, et al.
Proceedings of the National Academy of Sciences (2006) Vol. 103, Iss. 38, pp. 14116-14121
Open Access | Times Cited: 114
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
Liqiang Xi, Andrew Feber, Vanita Gupta, et al.
Nucleic Acids Research (2008) Vol. 36, Iss. 20, pp. 6535-6547
Open Access | Times Cited: 107
Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
Virginie Quidville, Samar Alsafadi, Aïcha Goubar, et al.
Cancer Research (2013) Vol. 73, Iss. 7, pp. 2247-2258
Open Access | Times Cited: 99
Wrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulators
Vladimir N. Uversky
Frontiers in Molecular Biosciences (2014) Vol. 1
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top